BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19588519)

  • 1. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
    Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
    Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
    Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
    Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
    J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
    Leal-Leal CA; Imaz-Olguín V; Robles-Castro J; Shalkow-Klincovstein J; Palacios-Acosta JM
    Ann Hepatol; 2010; 9(1):75-9. PubMed ID: 20308725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.
    Malogolowkin MH; Katzenstein HM; Meyers RL; Krailo MD; Rowland JM; Haas J; Finegold MJ
    J Clin Oncol; 2011 Aug; 29(24):3301-6. PubMed ID: 21768450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
    J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
    Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
    BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.
    Meyers RL; Tiao G; de Ville de Goyet J; Superina R; Aronson DC
    Curr Opin Pediatr; 2014 Feb; 26(1):29-36. PubMed ID: 24362406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
    Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
    Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).
    Towbin AJ; Meyers RL; Woodley H; Miyazaki O; Weldon CB; Morland B; Hiyama E; Czauderna P; Roebuck DJ; Tiao GM
    Pediatr Radiol; 2018 Apr; 48(4):536-554. PubMed ID: 29427028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
    Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
    BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
    Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
    Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China.
    Huang J; Hu Y; Jiang H; Xu Y; Lu S; Sun F; Zhu J; Wang J; Sun X; Liu J; Zhen Z; Zhang Y
    Front Oncol; 2020; 10():552079. PubMed ID: 33312943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and prognostic analysis of hepatoblastoma in children under six years old].
    Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
    Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1063-1068. PubMed ID: 34933424
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
    Brown J; Perilongo G; Shafford E; Keeling J; Pritchard J; Brock P; Dicks-Mireaux C; Phillips A; Vos A; Plaschkes J
    Eur J Cancer; 2000 Jul; 36(11):1418-25. PubMed ID: 10899656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.